Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zileze 3.75 tablets
0401010Z0BCAAAC
|
Zileze | Zopiclone | Central Nervous System | No data available |
|
Zileze 7.5 tablets
0401010Z0BCABAA
|
Zileze | Zopiclone | Central Nervous System | No data available |
|
Zimbacol XL 400mg tablets
0212000D0BEAAAB
|
Zimbacol | Bezafibrate | Cardiovascular System | No data available |
|
Zinacef 1.5g powder for solution for injection vials
0501021J0BBACAC
|
Zinacef | Cefuroxime sodium | Infections | No data available |
|
Zinacef 250mg powder for solution for injection vials
0501021J0BBAAAA
|
Zinacef | Cefuroxime sodium | Infections | No data available |
|
Zinacef 750mg powder for solution for injection vials
0501021J0BBABAB
|
Zinacef | Cefuroxime sodium | Infections | No data available |
|
Zinamide 500mg tablets
0501090N0BBABCJ
|
Zinamide | Pyrazinamide | Infections | No data available |
|
Zinbryta 150mg/1ml solution for injection pre-filled pens
0802040AZBBAAAA
|
Zinbryta | Daclizumab (Immunomodulating) | Malignant Disease and Immunosuppression | No data available |
|
Zinc and Ichthammol cream
1305010J0AAABAB
|
Ichthammol (Topical) | Ichthammol | Skin | No data available |
|
Zinc citrate 15mg capsules
090504100AABDBD
|
Generic compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | No data available |
|
Zinc citrate 15mg tablets
090504100AABCBC
|
Generic compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | No data available |
|
Zinc compound paste
130101000AAARAR
|
Generic compound preparation BNF 1301010 | Other vehicle and emulsifying agent preparations | Skin | No data available |
|
Zinc cream
1302020E0AAAAAA
|
Zinc oxide | Zinc oxide | Skin | No data available |
|
Zinc ointment
1302020E0AAABAB
|
Zinc oxide | Zinc oxide | Skin | No data available |
|
Zinc oxide 15% / Ichthammol 1% ointment
131500000AABCBC
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Zinc oxide 15mg tablets
090504100AABABA
|
Generic compound preparation BNF 0905041 | Other zinc preparations | Nutrition and Blood | No data available |
|
Zinc oxide 38% / Cod liver oil 11.4% ointment
1302020F0AAABAB
|
Cod liver oil (Topical) | Cod liver oil | Skin | No data available |
|
Zinc oxide 8.1% / Hydrous wool fat 4% cream
130201000AAAXAX
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Zinc oxide adhesive ostomy plaster 102mm x 102mm
23050600501
|
Zinc oxide adhesive ostomy plaster 102mm x 102mm | Adhesive Discs/Rings/Pads/Plasters | Stoma Appliances | No data available |
|
Zinc oxide adhesive ostomy plaster 127mm x 127mm
23050600502
|
Zinc oxide adhesive ostomy plaster 127mm x 127mm | Adhesive Discs/Rings/Pads/Plasters | Stoma Appliances | No data available |
|
Zinc oxide adhesive ostomy plaster 89mm x 89mm
23050600500
|
Zinc oxide adhesive ostomy plaster 89mm x 89mm | Adhesive Discs/Rings/Pads/Plasters | Stoma Appliances | No data available |
|
Zinc oxide powder
190400000AASDSD
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Zinc paste 15% and Ichthammol 2% bandage BP 1993 7.5cm x 6m
1305010AEAAAAAA
|
Zinc paste and ichthammol | Zinc paste and ichthammol | Skin | No data available |
|
Zinc paste and Calamine bandage 7.5cm x 6m
1305010ACAAAAAA
|
Zinc paste and calamine | Zinc paste and calamine | Skin | No data available |
|
Zinc paste, Calamine and Clioquinol bandage BP 7.5cm x 6m
1305010ADAAAAAA
|
Zinc paste, calamine and clioquinol | Zinc paste, calamine and clioquinol | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.